Rheumatology
1021 – 1030 of 1580
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
(
- Contribution to journal › Article
-
Mark
Association of Biomarkers With Pre-Radiographically Defined and Radiographically Defined Knee Osteoarthritis in a Population-Based Study
(
- Contribution to journal › Article
-
Mark
Very Early Intervention Is Crucial to Improve Work Outcome in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
(
- Contribution to journal › Article
-
Mark
From aggrecan to matrix
2009) Annual General Meeting of the British-Society-for-Matrix-Biology In International Journal of Experimental Pathology 90(2). p.93-93(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term follow-up of RA patients of the Hellenic Biologics Registry: comparison of first versus second anti-TNF-alpha therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
(
- Contribution to journal › Article
-
Mark
The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
(
- Contribution to journal › Article
-
Mark
The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Geriatric rheumatoid arthritis patients on delayed anti-TF-alpha agents have higher disease activity and experience more often serious adverse events compared to younger adults
(
- Contribution to journal › Published meeting abstract